Kalydeco

A Non-Profit, A Vertex Drug And Conflicts Of Interest

A Non-Profit, A Vertex Drug And Conflicts Of Interest

Pharmalot

Worth Repeating: Vertex Is The Next Gilead Sciences

Worth Repeating: Vertex Is The Next Gilead Sciences

TheStreet.com

Vertex Gains as Cystic Fibrosis Combo Eases Breathing

Vertex Gains as Cystic Fibrosis Combo Eases Breathing

Bloomberg

Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise

Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise

Seeking Alpha

Vertex Refocuses Drug Development to Specialty Diseases

Vertex Refocuses Drug Development to Specialty Diseases

Bloomberg

The Most Important New Drug Of 2012

The Most Important New Drug Of 2012

Forbes

Will Kalydeco Push Vertex Higher?

Will Kalydeco Push Vertex Higher?

Motley Fool

Vertex says Health Canada approves KALYDECO

Vertex says Health Canada approves KALYDECO

The Fly on the Wall

Vertex Gets Uneasy On Mixed Clinical Trial Results

Vertex Gets Uneasy On Mixed Clinical Trial Results

Seeking Alpha

Five Cystic Fibrosis Questions for Vertex Pharma

Five Cystic Fibrosis Questions for Vertex Pharma

TheStreet.com